Tulathromycin

Tulathromycin
Systematic (IUPAC) name
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-13-[[2,6-dideoxy-3-C-methyl-3-Ο-methyl-4-C-[(propylamino)methyl]-α-L-ribo-hexopyrano-syl]oxy]-2-ethyl-3,4,10-trihydroxy-3,5,8,10,12,14-hexamethyl-11-[[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]-oxy]-1-oxa-6-azacyclopentadecan-15-one
Clinical data
AHFS/Drugs.com International Drug Names
Identifiers
CAS Number 217500-96-4
ATCvet code QJ01FA94
ChemSpider 24583287 YesY
UNII Q839I13422 YesY
KEGG D06258 YesY
Chemical data
Formula C41H79N3O12
Molar mass 806.08 g/mol
  (verify)

Tulathromycin is a macrolide antibiotic used to treat bovine respiratory disease (BRD) in cattle and swine respiratory disease in pigs. It is marketed by Pfizer Inc. under the tradename Draxxin.

It is supplied as a solution for injection containing 100 mg of the drug. [1]

References

  1. Draxxin at draxxin.com

External links


This article is issued from Wikipedia - version of the Friday, September 02, 2011. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.